Literature DB >> 73215

Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate.

A C Teger-Nilsson, P Friberger, E Gyzander.   

Abstract

A method for determination of antiplasmin activity is presented. Plasmin and plasma are incubated, and the remaining plasmin activity is measured spectrophotometrically by means of the plasmin specific tripeptide substrate H-d-Val-l-Leu-l-Lys-p-nitroanilide. The method is simple, rapid and easily automatized. By the immunoadsorption technique, and with the aid of purified substances it is shown that the measured activity is mainly due to a new antiplasmin [2,4] and possibly to some extent to alpha1-antitrypsin and C1-esterase inhibitor have no antiplasmin activity in the method. Heparin and epsilonaminocaproic acid interfered with the assay.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 73215

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  24 in total

1.  Hyperfibrinolysis in hepatosplenic schistosomiasis.

Authors:  N E el-Bassiouni; A E el Bassiouny; H R el-Khayat; M M Akl; S A Omran
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Haemostatic function in myocardial infarction.

Authors:  A Hamsten; M Blombäck; B Wiman; J Svensson; A Szamosi; U de Faire; L Mettinger
Journal:  Br Heart J       Date:  1986-01

3.  Consumption of fibrinolytic proteins in menstrual fluid from women with normal menstrual blood loss.

Authors:  S A Cederholm-Williams; M C Rees; A C Turnbull
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

Review 4.  Natural inhibitors of fibrinolysis.

Authors:  D Collen
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

5.  Concentration of plasminogen and antiplasmin in plasma and serum.

Authors:  S A Cederholm-Williams
Journal:  J Clin Pathol       Date:  1981-09       Impact factor: 3.411

6.  Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).

Authors:  W Cullmann; P M Kövary; N Müller; W Dick
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

7.  Fibrinolysis-coagulation system in patients with cancer of the head and neck. Preliminary report.

Authors:  T Kosugi; I Takagi; Y Ariga; S Okada; T Morimitsu; H Mihara
Journal:  Arch Otorhinolaryngol       Date:  1982

8.  The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils.

Authors:  Enrico Lupia; Lorenzo Del Sorbo; Serena Bergerone; Giorgio Emanuelli; Giovanni Camussi; Giuseppe Montrucchio
Journal:  Immunology       Date:  2003-08       Impact factor: 7.397

9.  Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.

Authors:  J Aznar; A Estellés; G Tormo; P Sapena; V Tormo; S Blanch; F España
Journal:  Br Heart J       Date:  1988-05

10.  Congenital deficiency of alpha 2-plasmin inhibitor associated with severe hemorrhagic tendency.

Authors:  N Aoki; H Saito; T Kamiya; K Koie; Y Sakata; M Kobakura
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.